Given the support from the White House, it seems remarkable how slow the trial and data process is, with the company remaining vague about an NDA. Lesser drugs with more significant side effects have obtained early approval, yet in a situation where nothing has changed significantly for years, I think I can hear the faint sound of arses dragging on the ground.
Given the support from the White House, it seems remarkable how...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)